Clinical trial · Interventional
Effect of Oncothermia on Improvement of Quality of Life in Unresectable Pancreatic Cancer Patients
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Patients with pancreatic cancer often suffer from pain. Because of such a pain, their quality of life have seriously deteriorated. There have been a few studies that showed an effect for pain control by hyperthermia (heating the patient's body). However, there are several limitations in conventional hyperthermia. In this study, the investigators tried to show the effect of "Oncothermia" which is more selective to malignant tissue than conventional hyperthermia for pain control, increasing quality of life, and anti-tumor treatment.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer, Pancreas | Pancreatic Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Oncothermia | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Oncothermia group
- description
- Patients were treated with oncothermia 2 or 3 times a week. Treatment was performed for about 1 hours per each visits.
- interventionNames
- Other: Oncothermia
Primary outcomes (1)
- measure
- ECOG score change
- timeFrame
- 3 months after oncothermia treatment
Secondary outcomes (1)
- measure
- Progression free survival rate
- timeFrame
- 3 months later after oncothermia treatment
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * Inoperable or recurred pancreatic ductal adenocarcinoma * After the each cycle of chemotherapy, the disease status was "stable disease" Exclusion Criteria: * Person who has an experience of hyperthermia treatment * Person who has a difficulty of sensing heat * Person who has a skin graft or breast reconstruction surgery * Person who has a cardiac pacemaker or an implanted metal * Pregnant or breast feeding women * Person with uncontrolled infection, diabetes, hypertension, ischemic heart disease, myocardial infarct within 6 months * Person who was treated with unproved drugs within 6 months * Person who have a serious disease which can affect the person's safety * Person who do not consent to the study
References
Publications (0)
Data not yet available